Gene · 22925
Papers2,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Ribbon-like Electron-Dense Deposits in the Subepithelial Layer of Diffuse and Global Glomerular Basement Membrane in Neural Epidermal Growth Factor-like 1-Positive Membranous Nephropathy: A Case Report. | Kidney Med | 2025 | 41550382 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Serum Anti-phospholipase A2 Receptor (PLA2R) Antibody Assays for Membranous Nephropathy in Patients With Nephrotic Syndrome: A Systematic Review. | Cureus | 2025 | 41458753 | PubTator, text mining | PubMed |
| Membranous nephropathy in Kimura disease: A case report and literature review on renal biopsy findings. | Clin Nephrol Case Stud | 2025 | 41445719 | PubTator, text mining | PubMed |
| Anti-PLA2R Antibody-Positive Membranous Nephropathy Superimposed by Pleural Tuberculosis a Year Later: Mere Association or Actual Cause? | Saudi J Kidney Dis Transpl | 2025 | 41431911 | PubTator, text mining | PubMed |
| Discrepant Biopsy and Serological Findings in Nephrotic Syndrome: A Case of Phospholipase A2 Receptor (PLA2R)-Positive Membranous Nephropathy Mimicking Post-infectious Glomerulonephritis. | Cureus | 2025 | 41426863 | PubTator, text mining | PubMed |
| Balancing Bleeding and Thrombosis: A Rare Case of Hereditary Hemorrhagic Telangiectasia With Antiphospholipid Syndrome. | Cureus | 2025 | 41426769 | PubTator, text mining | PubMed |
| Serum and urine anti-PLA2R antibody correlation with albuminuria in idiopathic membranous nephropathy. | Front Immunol | 2025 | 41409272 | PubTator, text mining | PubMed |
| Real-World Utility of Immunoglobulin G4 Subtype Phospholipase A2 Receptor Autoantibodies in Diagnosing Phospholipase A2 Receptor-Associated Membranous Nephropathy. | Arch Pathol Lab Med | 2025 | 41401828 | PubTator, text mining | PubMed |
| Membranous nephropathy - an antigen-specific disease: a paradigm shift in the understanding of this disease. | Int J Clin Exp Pathol | 2025 | 41393973 | PubTator, text mining | PubMed |
| Treatment options for patients with high anti-PLA2R antibodies in primary membranous nephropathy: a single-center cohort retrospective study. | BMC Nephrol | 2025 | 41372817 | PubTator, text mining | PubMed |
| Urinary betaine/creatinine ratio enhances diagnostic accuracy of PLA2R-Ab in idiopathic membranous nephropathy. | BMC Nephrol | 2025 | 41361423 | PubTator, text mining | PubMed |
| The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial. | EClinicalMedicine | 2025 | 41324008 | PubTator, text mining | PubMed |
| Anti-nephrin antibodies in minimal change disease: Case report series. | Clin Nephrol | 2025 | 41307423 | PubTator, text mining | PubMed |
| Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study. | Front Immunol | 2025 | 41306981 | PubTator, text mining | PubMed |
| The Rare Occurrence of Tissue PLA2R-Positive Membranous Nephropathy in a Patient With Sjögren's Syndrome and Renal Tubular Acidosis. | Br J Hosp Med (Lond) | 2025 | 41284241 | PubTator, text mining | PubMed |
| Concurrent anti-glomerular basement membrane disease and membranous nephropathy: a case report. | Front Med (Lausanne) | 2025 | 41262443 | PubTator, text mining | PubMed |
| A study on the association between serum antiphospholipase A2 receptor antibodies and the hypercoagulable state in Chinese patients with primary membranous nephropathy. | Ren Fail | 2025 | 41233142 | PubTator, text mining | PubMed |
| A Clot and a Clue: When Pulmonary Embolism Leads to a Renal Diagnosis. | Cureus | 2025 | 41230298 | PubTator, text mining | PubMed |
| Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab? | Drug Des Devel Ther | 2025 | 41229922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22925/papers?page=8